Search
for
Sort by
Research 61–90 of 291
- Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial
- A Founder Mutation in the <i>POMC</i> 5′-UTR Causes Proopiomelanocortin Deficiency Through Splicing-Mediated Decrease of mRNA
- Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario
- ZALCITABINE
- Prevalence of hair loss in Egyptian people after covid -19 vaccination.
- New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
- An industry update: what’s new in the field of therapeutic delivery this month?
- Why Do Promising Therapies Stall in Development and How Can We Move Them Forward?
- Further errors in polymorph identification: furosemide and finasteride
- Epidural needle for recipient site preparation in hair restoration surgery
- THU0189 Safety of four treatment regimens in early rheumatoid arthritis
- Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- TRPA1 Modulates Mechanotransduction in Cutaneous Sensory Neurons
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Dermatological adverse events with taxane chemotherapy
- Inhibition of β-catenin signalling in dermal fibroblasts enhances hair follicle regeneration during wound healing
- What causes hidradenitis suppurativa ?—15 years after
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Effect of Platelet-Rich Plasma Injection for Rejuvenation of Photoaged Facial Skin
- Hidradenitis Suppurativa in Children and Adolescents: A Review of Treatment Options
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Interaction between stem cell factor and endothelin-1: effects on melanogenesis in human skin xenografts
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology